Allostery Investments LP Bridge Bio Pharma, Inc. Transaction History
Allostery Investments LP
- $7.85 Billion
- Q2 2025
A detailed history of Allostery Investments LP transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 4,000 shares of BBIO stock, worth $213,120. This represents 2.2% of its overall portfolio holdings.
Number of Shares
4,000
Previous 80,000
95.0%
Holding current value
$213,120
Previous $2.77 Billion
93.75%
% of portfolio
2.2%
Previous 3.99%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
408Shares Held
188MCall Options Held
11.3MPut Options Held
2.2M-
Viking Global Investors LP18.6MShares$989 Million2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$878 Million0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$707 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$663 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X09.28MShares$494 Million0.21% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $7.9B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...